港股周观点：开门红下的暗流-20260112

Group 1 - The report indicates that global markets mostly rose during the week of January 5-9, 2026, with the Hang Seng Index declining by 0.4% and the Hang Seng Tech Index down by 0.9% [1] - The healthcare sector led gains with a 10.1% increase, while telecommunications and information technology sectors faced declines of 2.3% and 1.6%, respectively [1] - The report highlights a significant inflow of southbound funds, totaling 32.65 billion HKD, although its proportion of total trading volume decreased from 51% to 45% [1][2] Group 2 - Investors show strong consensus on which Hong Kong stocks to buy, but there is a lack of consensus regarding potential short-term risks [3] - The report notes that expectations for a delay in the Federal Reserve's interest rate cuts could impact the rebound of Hong Kong stocks, with predictions suggesting only 1-2 rate cuts in 2026 [3] - Key risk factors include the potential ruling on the IEEPA Act and upcoming earnings reports from US tech companies, which could influence market sentiment [3][4] Group 3 - The report recommends maintaining a barbell strategy for overall portfolio allocation, suggesting a focus on value dividends as a base and aggressive positions in AI technology, non-ferrous metals, and innovative pharmaceuticals [4] - Upcoming events to watch include the JPM Healthcare Conference and key economic data releases from China and the US, which could impact market dynamics [5]